Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MMP14 | P50281 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.41 |
| ▸ | MMP9 | P14780 | 2/20 | 0.41 |
| ▸ | MMP13 | P45452 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL198192 | 0.87 | KDM4E (0.43) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL15397154 | 0.83 | NR4A2 (0.42) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL29722019 | 0.83 | NR4A2 (0.42) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL29503951 | 0.79 | KDM4E (0.50) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL440421 | 0.79 | KDM4E (0.50) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL11391 | 0.77 | KDM4E (0.46) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL318769 | 0.77 | NR4A2 (0.68) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL29410781 | 0.77 | NR4A2 (0.68) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL15255189 | 0.77 | KDM4E (0.48) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL30969487 | 0.75 | NR4A2 (0.37) | NR4A2KDM4EALDH1A1TDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1075478-B1 | PHENYLUREA AND PHENYLTHIO UREA DERIVATIVES | SMITHKLINE BEECHAM PLC (GB) | 2003-04-16 | — | — | EP | claimed |
| CN-116082369-A | Organic electroluminescent material based on triazolopyridine and organic electroluminescent device | 武汉尚赛光电科技有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-110452689-B | Triazolopyridine-based organic electroluminescent material and organic electroluminescent device | 武汉尚赛光电科技有限公司 | 2023-02-28 | — | — | CN | disclosed |
| US-10392395-B2 | Nitrogen-containing aromatic compounds and metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-08-27 | — | — | US | disclosed |
| EP-2493890-B1 | NITROGEN-CONTAINING AROMATIC COMPOUNDS AND METAL COMPLEXES | SUMITOMO CHEMICAL CO (JP) | 2018-03-21 | — | — | EP | disclosed |
| US-20140066290-A1 | CATHODE CATALYST FOR AIR SECONDARY BATTERY AND AIR SECONDARY BATTERY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-03-06 | — | — | US | disclosed |
| US-20140066290-A1 | CATHODE CATALYST FOR AIR SECONDARY BATTERY AND AIR SECONDARY BATTERY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-03-06 | — | — | US | disclosed |
| WO-2011052805-A1 | NITROGEN-CONTAINING AROMATIC COMPOUNDS AND METAL COMPLEXES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10392395-B2 | Nitrogen-containing aromatic compounds and metal complexes | TYR, MT-CO2, SOD1 | NR4A2 279/4885KDM4E 563/4885ALDH1A1 2123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.